Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Feb 2;14:1125576. doi: 10.3389/fphar.2023.1125576

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Grymonprez, De Backer, Bertels, Steurbaut and Lahousse.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Effectiveness and safety of individual NOACs versus VKAs after IPTW. The weighted number of subjects at risk in the pseudopopulation, weighted number of events, weighted event rates per 100 PY and adjusted HRs with 95%CIs after IPTW are illustrated. CI: confidence interval; CRNMB: clinically relevant non-major bleeding; (a)HR: (adjusted) hazard ratio; IPTW: inverse probability of treatment weighting; MB: major bleeding; NOAC: non-vitamin K antagonist oral anticoagulant; PY: person-years; Ref: reference category; SE: systemic embolism; VKA: vitamin K antagonist; vs. versus.